Profil
Yumeng Wang currently works at General Atlantic Asia Ltd., as Vice President.
Ms. Wang also formerly worked at Biotheus, Inc., as Non-Executive Director, Ocumension Therapeutics, as Non-Executive Director, and Adagene, Inc., as Director from 2023 to 2025.
Ms. Wang received her undergraduate degree in 2013 from The Hong Kong University of Science & Technology and graduate degree in 2021 from The Hong Kong University of Science & Technology.
Postes actifs de Yumeng Wang
| Sociétés | Poste | Début |
|---|---|---|
General Atlantic Asia Ltd.
General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd invests in companies located in the US. It targets the companies operating in the fields of consumer, financial services, healthcare and Technology. It provides financing for growth transactions. | Analyste en capital-investissement | 01/01/2017 |
Anciens postes connus de Yumeng Wang
| Sociétés | Poste | Fin |
|---|---|---|
| ADAGENE INC. | Directeur/Membre du Conseil | 24/03/2025 |
| OCUMENSION THERAPEUTICS | Directeur/Membre du Conseil | 21/10/2024 |
Biotheus, Inc.
Biotheus, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel antibodies for oncology and inflammatory diseases | Directeur/Membre du Conseil | - |
Formation de Yumeng Wang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Hong Kong University of Science & Technology
The Hong Kong University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
General Atlantic Asia Ltd.
General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd invests in companies located in the US. It targets the companies operating in the fields of consumer, financial services, healthcare and Technology. It provides financing for growth transactions. | Finance |
Adagene, Inc.
Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
Biotheus, Inc.
Biotheus, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel antibodies for oncology and inflammatory diseases | Commercial Services |
Ocumension Therapeutics
Ocumension Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as an ophthalmic pharmaceutical platform company that develops drugs | Commercial Services |
















